#drug
NORD Applauds FDA Initiative to Establish New Regulatory Framework for Rare Disease Drug Development
NORWELL, Mass. — The National Organization for Rare Disorders (NORD®) has issued a strong statement of support for...
National Organization for Rare Disorders Mourns the Passing of Former U.S. Senator Nancy Kassebaum Baker, Champion of the Orphan Drug Act
The National Organization for Rare Disorders (NORD) has expressed its profound sorrow following the passing of former U.S....
New KFF Analysis Finds TrumpRx Brand-Name Drug Prices Often Equal to Other Wealthy Nations
Consumers purchasing brand-name prescription drugs without an available generic or biosimilar through the newly launched TrumpRx website face...
TrumpRx Brand-Name Drug Prices Show Mixed Results Compared to Other Wealthy Nations, Analysis Finds
WASHINGTON — Prices for brand-name medications available through TrumpRx are roughly as likely to be higher as they are to...
Yale Preclinical Study Reveals Epilepsy Drug Delivered via Hydrogel Could Reverse Osteoarthritis and Relieve Joint Pain
For millions of people worldwide living with osteoarthritis, daily life is frequently characterized by a frustrating and often debilitating cycle...
Former U.S. Senator Nancy Kassebaum Baker Remembered for Transformative Role in Rare Disease Legislation and the Passage of the Orphan Drug Act
The National Organization for Rare Disorders (NORD) has expressed its profound sorrow following the passing of former U.S. Senator Nancy...